Sorrento Therapeutics, Inc. (SRNEQ)

OTCMKTS: SRNEQ · Delayed Price · USD
0.0030
-0.0050 (-62.50%)
Mar 28, 2024, 9:30 AM EDT - Market open

Total Valuation

SRNEQ has a market cap or net worth of $4.41 million. The enterprise value is $440.30 million.

Market Cap 4.41M
Enterprise Value 440.30M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

SRNEQ has 551.28 million shares outstanding. The number of shares has increased by 36.86% in one year.

Shares Outstanding 551.28M
Shares Change (YoY) +36.86%
Shares Change (QoQ) +1.50%
Owned by Insiders (%) 0.89%
Owned by Institutions (%) 0.08%
Float 538.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.07
Forward PS 0.09
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 6.85
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.50

Current Ratio 0.50
Quick Ratio 0.43
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -78.11

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -109.30%
Return on Capital (ROIC) -162.13%
Revenue Per Employee $67,724
Profits Per Employee -$577,551
Employee Count 949
Asset Turnover 0.13
Inventory Turnover 2.35

Taxes

In the past 12 months, SRNEQ has paid $9.31 million in taxes.

Income Tax 9.31M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -97.54% in the last 52 weeks. The beta is 2.38, so SRNEQ's price volatility has been higher than the market average.

Beta (1Y) 2.38
52-Week Price Change -97.54%
50-Day Moving Average 0.03
200-Day Moving Average 0.13
Relative Strength Index (RSI) 42.83
Average Volume (30 Days) 652,429

Short Selling Information

The latest short interest is 64.56 million, so 11.71% of the outstanding shares have been sold short.

Short Interest 64.56M
Short Previous Month 61.44M
Short % of Shares Out 11.71%
Short % of Float 11.98%
Short Ratio (days to cover) 4.96

Income Statement

In the last 12 months, SRNEQ had revenue of $64.27 million and -$548.10 million in losses. Loss per share was -$1.12.

Revenue 64.27M
Gross Profit 28.64M
Operating Income -504.88M
Pretax Income -538.79M
Net Income -548.10M
EBITDA -512.57M
EBIT -531.98M
Loss Per Share -$1.12
Full Income Statement

Balance Sheet

The company has $80.64 million in cash and $516.52 million in debt, giving a net cash position of -$435.89 million or -$0.79 per share.

Cash & Cash Equivalents 80.64M
Total Debt 516.52M
Net Cash -435.89M
Net Cash Per Share -$0.79
Equity / Book Value -205.11M
Book Value Per Share -0.37
Working Capital -131.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$234.63 million and capital expenditures -$8.59 million, giving a free cash flow of -$243.21 million.

Operating Cash Flow -234.63M
Capital Expenditures -8.59M
Free Cash Flow -243.21M
FCF Per Share -$0.44
Full Cash Flow Statement

Margins

Gross margin is 44.56%, with operating and profit margins of -785.56% and -852.80%.

Gross Margin 44.56%
Operating Margin -785.56%
Pretax Margin -838.32%
Profit Margin -852.80%
EBITDA Margin -797.52%
EBIT Margin -827.72%
FCF Margin -378.42%

Dividends & Yields

SRNEQ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -36.86%
Shareholder Yield -36.86%
Earnings Yield -12,427.78%
FCF Yield -5,514.70%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on August 1, 2013. It was a reverse split with a ratio of 1:25.

Last Split Date Aug 1, 2013
Split Type Reverse
Split Ratio 1:25

Scores

SRNEQ has an Altman Z-Score of -10.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -10.77
Piotroski F-Score 2